CAV1 and breast carcinoma: Our results also demonstrated that CAV1 expression was highly elevated in paclitaxel-resistant breast cancer cells, and ADQ chemosensitized breast cancer cells by inhibiting CAV1, consistent with the oncogenic role of CAV1.